Cardiovascular Diagnostics Files Two 510k Applications for Three New Products.
Business Wire › March 22, 1999
Linked as:
Extract
Cardiovascular Diagnostics Files Two 510k Applications for Three New Products.
RALEIGH, N.C.--(BW HealthWire)--March 22, 1999--PharmaNetics, Inc. (NASDAQ NM: PHAR), a holding company of Cardiovascular Diagnostics, Inc., today announced that the Company has filed two 510(k) submissions with the FDA.
The first submis...See the full content of this document
Sponsored links
